Cited by 35Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disorders and Treatments

Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional Study

Tadokoro, Koh, Morihara, Ryuta, Ohta, Yasuyuki, Hishikawa, Nozomi, Kawano, Satoko, Sasaki, Ryo, Matsumoto, Namiko, Nomura, Emi +19 more·2019·Journal of Alzheimer s Disease

Abstract

Oxidative stress is part of the entire pathological process that underlies the development of Alzheimer's disease (AD), including the mild cognitive impairment (MCI) stage. Twendee X (TwX) is a supplement containing a strong antioxidative mix of eight antioxidants, which has been shown to have a clinical and therapeutic benefit in AD model mice. Here, we conducted a multicenter, randomized, double-blind, and placebo-controlled prospective interventional study to evaluate the efficacy of TwX in mitigating MCI. The primary outcomes were differences in Mini-Mental State Examination (MMSE) and Hasegawa Dementia Scale-revised (HDS-R) scores between baseline and six months for placebo and TwX groups. Seventy-eight subjects with MCI were randomized into placebo (n = 37) and TwX (n = 41) groups. MMSE scores at six months differed significantly between the TwX and placebo groups (p = 0.018), and HDS-R scores for the TwX group exhibited a significant improvement at six months relative to baseline (p = 0.025). The TwX group did not show any change in affective or activities of daily living scores at six months. The present study indicates that strong antioxidative supplement TwX is clinical beneficial for cognitive function in subjects with MCI.

Integrity signals

Registry

Crossref · 10.3233/jad-190644

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 42 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Tadokoro, K., Morihara, R., Ohta, Y., Hishikawa, N., Kawano, S., Sasaki, R., Matsumoto, N., Nomura, E., Nakano, Y., Takahashi, Y., Takemoto, M., Yamashita, T., Ueno, S., Wakutani, Y., Takao, Y., Morimoto, N., Kutoku, Y., Sunada, Y., Taomoto, K., Manabe, Y., Deguchi, K., Higashi, Y., Inufusa, H., You, F., Yoshikawa, T., von Greiffenclau, M. M., & Abe, K.
Affiliations
  • Okayama University (JP)
  • Department of Neurology, Kurashiki Heisei Hospital, Kurashiki, Japan
  • Kagawa Prefectural Central Hospital (JP)
  • Kawasaki Medical School (JP)
  • Ohnishi Neurological Center (JP)
  • Okayama Medical Center (JP)
  • Okayama City Hospital (JP)
  • Himeji Medical Center (JP)
  • Gifu University (JP)
  • Louis Pasteur Center for Medical Research (JP)
  • European Medical Foundation, TIMA Est., Balzers, Liechtenstein
Corresponding author
Abe, Koji
Venue
Journal of Alzheimer s Disease
Published
2019-08-24
Volume
71
Issue
3
Pages
1063-1069
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2970534723
Cited by
35
References
42
Citations by year
2026: 2 · 2025: 3 · 2024: 11 · 2023: 9 · 2022: 5 · 2021: 3 · 2020: 2
FWCI
1.99
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (17H04196)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
antioxidant supplements
MeSH terms
Mental Status and Dementia Tests, Activities of Daily Living, Aged, Aged, 80 and over, Antioxidants, Ascorbic Acid, Cognition, Cystine, Double-Blind Method, Female, Glutamine, Humans, Male, Prospective Studies, Treatment Outcome, Dietary Supplements, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review